|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61K 38/17 | |||
| A61P 35/00 |
| (11) | Number of the document | 3092006 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15735468.9 |
| Date of filing the European patent application | 2015-01-08 | |
| (97) | Date of publication of the European application | 2016-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010650 |
| Date | 2015-01-08 |
| (87) | Number | WO 2015/105995 |
| Date | 2015-07-16 |
| (30) | Number | Date | Country code |
| 201461925143 P | 2014-01-08 | US |
| (72) |
WEISKOPF, Kipp, Andrew, US
SAGE, Julien, US
WEISSMAN, Irving, L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | TARGETED THERAPY FOR SMALL CELL LUNG CANCER |
| TARGETED THERAPY FOR SMALL CELL LUNG CANCER |